newsfilter
← Latest News
GlobeNewswire·

Cerevel Therapeutics Reports Second Quarter 2023 Financial Results and Business Updates

Three new executives added to leadership team: Ron Renaud, Susan Altschuller, Paul Burgess Emraclidine EMPOWER data now expected second half 2024 Darigabat ADAPT trial in panic disorder initiated Cash, cash